Keywords: Prostate cancer, Market forecasts, Johnson & Johnson, Zytiga, Astellas, Xtandi, Patient population, Decision Resources

Prostate cancer drug market will more than double to $9.1 billion in 2021

Article | 06 November 2012

Print This

The prostate cancer drug market will more than double, increasing from $4.1 billion in 2011 to $9.1 billion in 2021 in the USA, France, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in